Psychemedics EBITDA Margin 2010-2024 | PMD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Psychemedics (PMD) over the last 10 years. The current EBITDA margin for Psychemedics as of December 31, 2024 is .
| Psychemedics EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-12-31 |
$0.02B |
$0.00B |
5.26% |
| 2024-09-30 |
$0.02B |
0 |
0.00% |
| 2024-06-30 |
$0.02B |
0 |
0.00% |
| 2024-03-31 |
$0.02B |
0 |
0.00% |
| 2023-12-31 |
$0.02B |
0 |
0.00% |
| 2023-09-30 |
$0.02B |
0 |
0.00% |
| 2023-06-30 |
$0.03B |
0 |
0.00% |
| 2023-03-31 |
$0.03B |
$0.00B |
3.85% |
| 2022-12-31 |
$0.03B |
$0.00B |
7.41% |
| 2022-09-30 |
$0.03B |
$0.00B |
7.41% |
| 2022-06-30 |
$0.03B |
$0.00B |
14.81% |
| 2022-03-31 |
$0.03B |
$0.00B |
15.38% |
| 2021-12-31 |
$0.03B |
$0.00B |
16.00% |
| 2021-09-30 |
$0.02B |
$0.00B |
16.67% |
| 2021-06-30 |
$0.02B |
$0.00B |
9.09% |
| 2021-03-31 |
$0.02B |
$0.00B |
-5.26% |
| 2020-12-31 |
$0.02B |
$0.00B |
-4.76% |
| 2020-09-30 |
$0.03B |
$0.00B |
-4.00% |
| 2020-06-30 |
$0.03B |
$0.00B |
3.33% |
| 2020-03-31 |
$0.04B |
$0.01B |
13.89% |
| 2019-12-31 |
$0.04B |
$0.01B |
15.79% |
| 2019-09-30 |
$0.04B |
$0.01B |
20.51% |
| 2019-06-30 |
$0.04B |
$0.01B |
22.50% |
| 2019-03-31 |
$0.04B |
$0.01B |
23.81% |
| 2018-12-31 |
$0.04B |
$0.01B |
25.58% |
| 2018-09-30 |
$0.04B |
$0.01B |
27.91% |
| 2018-06-30 |
$0.04B |
$0.01B |
28.57% |
| 2018-03-31 |
$0.04B |
$0.01B |
26.83% |
| 2017-12-31 |
$0.04B |
$0.01B |
27.50% |
| 2017-09-30 |
$0.04B |
$0.01B |
29.27% |
| 2017-06-30 |
$0.04B |
$0.01B |
32.56% |
| 2017-03-31 |
$0.04B |
$0.02B |
34.88% |
| 2016-12-31 |
$0.04B |
$0.01B |
32.50% |
| 2016-09-30 |
$0.04B |
$0.01B |
28.57% |
| 2016-06-30 |
$0.03B |
$0.01B |
20.00% |
| 2016-03-31 |
$0.03B |
$0.00B |
14.81% |
| 2015-12-31 |
$0.03B |
$0.00B |
14.81% |
| 2015-09-30 |
$0.03B |
$0.00B |
14.29% |
| 2015-06-30 |
$0.03B |
$0.01B |
17.24% |
| 2015-03-31 |
$0.03B |
$0.01B |
20.00% |
| 2014-12-31 |
$0.03B |
$0.01B |
20.00% |
| 2014-09-30 |
$0.03B |
$0.01B |
20.69% |
| 2014-06-30 |
$0.03B |
$0.01B |
21.43% |
| 2014-03-31 |
$0.03B |
$0.01B |
22.22% |
| 2013-12-31 |
$0.03B |
$0.01B |
23.08% |
| 2013-09-30 |
$0.03B |
$0.01B |
23.08% |
| 2013-06-30 |
$0.03B |
$0.01B |
24.00% |
| 2013-03-31 |
$0.03B |
$0.01B |
24.00% |
| 2012-12-31 |
$0.03B |
$0.01B |
28.00% |
| 2012-09-30 |
$0.03B |
$0.01B |
28.00% |
| 2012-06-30 |
$0.03B |
$0.01B |
28.00% |
| 2012-03-31 |
$0.02B |
$0.01B |
29.17% |
| 2011-12-31 |
$0.02B |
$0.01B |
29.17% |
| 2011-09-30 |
$0.02B |
$0.01B |
30.43% |
| 2011-06-30 |
$0.02B |
$0.01B |
27.27% |
| 2011-03-31 |
$0.02B |
$0.01B |
28.57% |
| 2010-12-31 |
$0.02B |
$0.01B |
26.32% |
| 2010-09-30 |
$0.02B |
$0.01B |
27.78% |
| 2010-06-30 |
$0.02B |
$0.01B |
27.78% |
| 2010-03-31 |
$0.02B |
$0.00B |
17.65% |
| 2009-12-31 |
$0.02B |
$0.00B |
11.76% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$0.020B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
